Furthermore, we demonstrate that chronic circadian clock disruption significantly impacts advanced hormone‐dependent prostate cancer progression, as evidenced by elevated serum levels of testosterone and increased expression of genes involved in intratumoral androgen biosynthesis (Figure 1B). This evidence concerns the gene CLOCK and prostate carcinoma.